In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use

With bankruptcy looming for Clovis Oncology, the company has defaulted on a loan by failing to make an interest payment that was due Nov. 1—with a 30-day grace period to Dec. 1, according to a securities filing.